Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 6Pancreatic Neoplasms 5Stomach Neoplasms 4Neoplasms 3Fatigue 3Carcinoma, Hepatocellular 3Urinary Bladder Neoplasms 2Sarcoma 2Rectal Neoplasms 2Prostatic Neoplasms 2Pain 2Lymphoma 2Gastrointestinal Neoplasms 2Esophageal Neoplasms 2Colonic Neoplasms 2Breast Neoplasms 2Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Stress Disorders, Post-Traumatic 1Recurrence 1Ovarian Neoplasms 1Myelodysplastic Syndromes 1Melanoma 1Lung Neoplasms 1Locally Advanced Colorectal Cancer 1Leukemia, Myeloid, Acute 1Leukemia 1Kidney Neoplasms 1Hemorrhage 1Hematologic Neoplasms 1

Interventions

Gemcitabine 113Cisplatin 77Oxaliplatin 46pembrolizumab 35Fluorouracil 33Capecitabine 31durvalumab 27Leucovorin 27lenvatinib 26Magnetic Resonance Spectroscopy 15Irinotecan 14Drug Therapy 13Biopsy 13Nivolumab 12Albumin-Bound Paclitaxel 12tislelizumab 11Specimen Handling 11Radiofrequency Ablation 11130-nm albumin-bound paclitaxel 11pemigatinib 10apatinib 10Taxes 10Radiotherapy 10Floxuridine 10Folfox protocol 9Bevacizumab 9S 1 (combination) 8Platinum 8Photochemotherapy 8Liver Transplantation 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cholangiocarcinoma × Palliative Care × Gastrointestinal × Clear all
NCT06369480 2024-04-17

Prognostic Factors for Survival in Patients With Cholangiocarcinoma

Rigshospitalet, Denmark

Unknown
2,000 enrolled
Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡